• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.69% Nasdaq Up 2.12%

    Orexigen Therapeutics, Inc. (OREX)

    -NasdaqGS
    6.38 Dec 17, 4:00PM EST
    |Pre-Market : 6.50 Up 0.12 (1.88%) 9:28AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:6.38
    Open:N/A
    Bid:6.50 x 600
    Ask:6.58 x 500
    1y Target Est:11.33
    Beta:3.87
    Earnings Date:Mar 10 - Mar 16 (Est.)
    Day's Range:N/A - N/A
    52wk Range:3.11 - 7.82
    Volume:7,662
    Avg Vol (3m):3,727,940
    Market Cap:785.80M
    P/E (ttm):N/A
    EPS (ttm):-0.53
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    OREX 0.00%785.80M
    ABT66.65B
    GSK101.06B
    RHHBY244.89B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):23.51
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.11
    Quarterly EPS Est (Dec-14) :0.23
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):-3.77

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback